AMPL vs AXTI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMPL's Piotroski F-Score of 2/9 indicates severe financial distress, with weak operational and accounting health. The absence of an Altman Z-Score and negative profitability metrics (ROE: -32.68%, ROA: -13.85%) underscore significant underlying weaknesses. Despite a 17% YoY revenue growth and strong gross margins (73.98%), the company remains unprofitable with a negative profit margin of -25.80%. Insider selling totaling $5.73M over six months and a bearish technical trend further erode confidence. The stock trades at a forward P/E of 42.85, well above the sector average, suggesting overvaluation relative to current earnings performance.
AXTI's deterministic health score is weak, with a Piotroski F-Score of 4/9 indicating borderline financial stability. Despite strong revenue growth of 18.2% and improving earnings trends, the company remains unprofitable with negative margins and ROE, undermining its fundamental strength. Valuation metrics are stretched relative to peers, while insider selling and inconsistent earnings beats suggest caution. However, analyst consensus remains at 'buy' and recent price momentum reflects market optimism about turnaround prospects.
Compare Another Pair
Related Comparisons
AMPL vs AXTI: Head-to-Head Comparison
This page compares Amplitude, Inc. (AMPL) and AXT, Inc. (AXTI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.